I don’t have a lot to report this week. We are still waiting for the government to reopen so we can hear about the timing of our site visit. So, I have focused on other things, including research and patient care.
Sadly, three of my patients with metastatic pancreatic cancer have died in the last few weeks. Each of them had a brief response to chemotherapy, and then their diseases roared back with a vengeance, despite all of our best efforts. I am fighting back the best way I know – by writing a new research proposal that focuses on this terrible disease.
On a related note my young patient with metastatic rectal cancer just got started on a clinical trial of cetuximab plus nilotinib led by Brandon Smaglo. We certainly hope he derives some benefit from this treatment. Fingers crossed!
Also, congratulations to Dick Schlegel, who will receive the President’s Awards for Distinguished Scholar-Teachers today at the University’s annual Fall Faculty Convocation in Gaston Hall at 5 pm. It is certainly well deserved. Congratulations, Dick!
